4.8 Article

Monocytic CCR2+ Myeloid-Derived Suppressor Cells Promote Immune Escape by Limiting Activated CD8 T-cell Infiltration into the Tumor Microenvironment

期刊

CANCER RESEARCH
卷 72, 期 4, 页码 876-886

出版社

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/0008-5472.CAN-11-1792

关键词

-

类别

资金

  1. NIH [KO8 AI071998]
  2. National Cancer Institute [R01 CA56821, P01 CA33049, P01 CA59350]
  3. American Cancer Society [MRSG-11-054-01-LIB]
  4. Melanoma Research Alliance
  5. The Lymphoma Foundation
  6. Medical Scientist Training Program [GM07739]
  7. Swim Across America
  8. Lita Annenberg Hazen Foundation
  9. T.J. Martell Foundation
  10. Mr. William H. Goodwin and Mrs. Alice Goodwin
  11. Commonwealth Cancer Foundation for Research

向作者/读者索取更多资源

Myeloid-derived suppressor cells (MDSC) are a heterogeneous population of cells that accumulate during tumor formation, facilitate immune escape, and enable tumor progression. MDSCs are important contributors to the development of an immunosuppressive tumor microenvironment that blocks the action of cytotoxic antitumor T effector cells. Heterogeneity in these cells poses a significant barrier to studying the in vivo contributions of individual MDSC subtypes. Herein, we show that granulocyte-macrophage colony stimulating factor, a cytokine critical for the numeric and functional development of MDSC populations, promotes expansion of a monocyte-derived MDSC population characterized by expression of CD11b and the chemokine receptor CCR2. Using a toxin-mediated ablation strategy to target CCR2-expressing cells, we show that these monocytic MDSCs regulate entry of activated CD8 T cells into the tumor site, thereby limiting the efficacy of immunotherapy. Our results argue that therapeutic targeting of monocytic MDSCs would enhance outcomes in immunotherapy. Cancer Res; 72(4); 876-86. (C) 2011 AACR.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据